GlassScriptPhysician profile
Farhan Javaid
NPI 1417966425
$6,400.51
in general payments reported to CMS, 2019-2025
41 companies · $768 in 2025
The $768 reported for 2025 was more than what 81% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,168 · 2020: $247 · 2021: $533 · 2022: $1,017 · 2023: $1,717 · 2024: $952 · 2025: $768.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,428 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,428.10 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,171.71 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $705.76 | 2019-2025 | |
| Lilly USA, LLC | $654.42 | 2019-2025 | Mounjaro, Trulicity, Jardiance |
| Pfizer INC. | $427.06 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $386.04 | 2019-2025 | |
| Amgen INC. | $359.20 | 2019-2025 | Otezla, Repatha, Prolia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $340.59 | 2021-2025 | Xifaxan, Trulance |
| Amarin Pharma, INC. | $270.42 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $250.48 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $191.59 | 2019-2024 | Spravato |
| Merck Sharp & Dohme LLC | $191.12 | 2019-2021 | |
| Abbott Laboratories | $189.08 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Biohaven Pharmaceutical Holding Company LTD. | $150.23 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $145.80 | 2019-2021 | |
| Intuitive Surgical, INC. | $124.74 | 2025 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farhan Javaid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.